RSS Feed Print
Mild Cognitive Impairment Trial
Posted: Wednesday, February 1, 2012 12:47 PM
Joined: 12/6/2011
Posts: 3326

From Alzheimer's Daily Report:

(Source: Globes) - Avraham Pharmaceuticals Ltd. has begun treatment of the first patient in a Phase II clinical trial of Ladostigil, for the treatment of mild cognitive impairment. The three-year safety and efficacy of the drug for this indication will include 200 patients at 12 medical centers in Israel and Europe. The company believes that patient recruitment will take one year.

Avraham Pharmaceuticals is also continuing the Phase IIb clinical trial of Ladostigil at a different dosage for the treatment of Alzheimer's disease. Last week, the company reported positive interim results in the safety and efficacy of the drug for treating Alzheimer's.

Go to full story:

Posted: Wednesday, February 1, 2012 2:20 PM
Joined: 12/5/2011
Posts: 795



Very interesting.


Thanks for sharing.


Peace and Hope,